Houston, TX, United States of America

Laszlo Radvanyi

USPTO Granted Patents = 8 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Richmond Hill, CA (2010 - 2015)
  • Houston, TX (US) (2010 - 2016)

Company Filing History:


Years Active: 2010-2016

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Laszlo Radvanyi

Introduction

Laszlo Radvanyi is a prominent inventor based in Houston, Texas, known for his significant contributions to the field of cancer immunotherapy. With a total of eight patents to his name, Radvanyi has made remarkable strides in understanding and treating cancer through innovative approaches.

Latest Patents

Among his latest patents, Radvanyi has developed a B and T lymphocyte attenuator marker for use in adoptive T-cell therapy. This invention highlights the role of BTLA-positive lymphocyte signaling in driving T cells to kill tumors. The BTLA functions as a positive modulator of anti-tumor T cell responses, particularly in melanoma cases. His research indicates that BTLA-positive T cells respond more effectively to interleukin-2 than their BTLA-negative counterparts, making them a valuable marker for selecting enriched anti-tumor reactive T cells for therapeutic applications. Additionally, Radvanyi has patented tumor antigens BFA4 and BCY1, which are aimed at preventing and treating cancer. This invention involves a nucleic acid encoding a polypeptide that can be utilized in immunotherapeutic treatments, showcasing improved vectors for gene insertion and expression.

Career Highlights

Radvanyi has worked with notable organizations, including Sanofi Pasteur Inc. and the University of Texas System. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer treatment.

Collaborations

Some of Radvanyi's notable coworkers include Neil L Berinstein and Corey Lovitt. Their collaborative efforts have further advanced the understanding of cancer immunotherapy and the development of innovative treatment strategies.

Conclusion

Laszlo Radvanyi's work exemplifies the impact of innovation in the medical field, particularly in cancer research and treatment. His patents and collaborations reflect a commitment to improving patient outcomes through advanced therapeutic techniques.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…